Key factors influencing lung cancer survival in northern Italy

Cancer Epidemiology

Volumn 37, Issue 3, 2013, Pages 226-232

  Mangone, Lucia ^a   Minicozzi, Pamela ^b   Vicentini, Massimo ^c   Giacomin, Adriano ^d   Caldarella, Adele ^e   Cirilli, Claudia ^f   Falcini, Fabio ^g   Giorgi Rossi, Paolo ^c   Sant, Milena ^b  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c PATHOLOGY UNIT   (Italy)

^d Piedmont Cancer Registry Province of Biella (CPO)   (Italy)

^e ISPO   (Italy)

^f MODENA CANCER REGISTRY   (Italy)

^g DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

Author keywords

Cancer registry; Italy; Lung cancer; Survival; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORPHOLOGY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; ITALY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK ASSESSMENT; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; ITALY; LUNG NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84876309833     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.02.005     Document Type: Article

References (33)

1. AIRT Working Group Italian cancer figures - report 2006: 1. Incidence, mortality and estimates. Epidemiol Prev 2006, 30:1-147.
2. AIRTUM Working Group Italian cancer figures - report 2007: survival. Epidemiol Prev 2007, 31:1-95.
3. Sant M., Allemani C., Santaquilani M., Knijn A., Marchesi F., Capocaccia R., et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009, 45:931-991.
4. Coleman M.P., Forman D., Bryant H., Butler J., Rachet B., Maringe C., et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011, 377:127-138.
5. Tan Y.K., Wee T.C., Koh W.P., Wang Y.T., Eng P., Tan W.C., et al. Survival among Chinese women with lung cancer in Singapore: a comparison by stage, histology and smoking status. Lung Cancer 2003, 40:237-246.
6. Wisnivesky J.P., Yankelevitz D., Henschke C.I. The effect of tumor size on curability of stage I non-small cell lung cancers. Chest 2004, 126:761-765.
7. Sant M., Minicozzi P., Allemani C., Cirilli C., Federico M., Capocaccia R., et al. Regional inequalities in cancer care persist in Italy and can influence survival. Cancer Epidemiol 2012, 36:541-547.
8. Xie L., Ugnat A.M., Morriss J., Semenciw R., Mao Y. Histology-related variation in the treatment and survival of patients with lung carcinoma in Canada. Lung Cancer 2003, 42:127-139.
9. Fazio L., Cotterchio M., Manno M., McLaughlin J., Gallinger S. Association between colonic screening, subject characteristics, and stage of colorectal cancer. Am J Gastroenterol 2005, 100:2531-2539.
10. Koyi H., Hillerdal G., Brandén E. A prospective study of a total material of lung cancer from a county in Sweden 1997-1999: gender, symptoms, type, stage, and smoking habits. Lung Cancer 2002, 36:9-14.
11. Alberts W.M. American College of Chest Physicians. Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines. Chest 2007, 132:1S-19S. (2nd ed.).
12. Aggarwal C., Langer C.J. Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer. Curr Opin Oncol 2012, 24:130-136.
13. EUROCARE Study. ; 2012. http://www.eurocare.it/.
14. Associazione italiana registri tumori. AIRTUM. ; 2012. http://www.registri-tumori.it/cms.
15. Fritz A., Jack A., Parkin D.M., Percy C., Shanmugarathan S., Sobin L., et al. International classification of diseases for oncology (ICD-O) 2000, WHO, Geneva. 3rd ed.
16. Sobin L.H., Wittekind C. TNM classification of malignant tumours 2002, John Wiley & Sons, New Jersey. 6th ed.
17. Brenner H., Gefeller O. Deriving more up-to-date estimates of long-term patient survival. J Clin Epidemiol 1997, 50:211-216.
18. Ederer F., Heise H. Instructions to IBM 650 Programmers in processing survival computations. Methodological note No.10, End Results Evaluation Section 1959, National Cancer Institute, Bethesda, MD.
19. Dickman P.W., Sloggett A., Hills M., Hakulinen T. Regression models for relative survival. Statist Med 2004, 23:51-64.
20. Sincich T. Statistics by example 1987, Dellen Publishing Company, San Francisco. 3rd ed.
21. StataCorp Stata statistical software release 12 2011, StataCorp LP, College Station, TX.
22. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents, vol. IX. IARC Scientific Publications No. 160. Lyon: IARC; 2007.
23. AIRTUM Working Group Italian cancer figures, report 2011: survival of cancer patients in Italy. Epidemiol Prev 2011, 35:1-200.
24. Brenner H., Francisci S., de Angelis R., Marcos-Gragera R., Verdecchia A., Gatta G., et al. Long-term survival expectations of cancer patients in Europe in 2000-2002. Eur J Cancer 2009, 45:1028-1041.
25. Biella Local Health Unit. ; 2011. http://www.aslbi.piemonte.it/modules.php?op=modload&name=News&file=article&sid=738&mode=thread&order=0&thold=0.
26. Bach P.B., Mirkin J.N., Oliver T.K., Azzoli C.G., Berry D.A., Brawley O.W., et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012, 307:2418-2429.
27. Wisnivesky J.P., Halm E.A. Sex differences in lung cancer survival: do tumors behave differently in elderly women?. J Clin Oncol 2007, 25:1705-1712.
28. Quaglia A., Tavilla A., Shack L., Brenner H., Janssen-Heijnen M., Allemani C., et al. The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer 2009, 45:1006-1016.
29. D'Addario G., Felip E., ESMO Guidelines Working Group Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009, 20:68-70.
30. Salmerón D., Chirlaque M.D., Izarzugaza M.I., Sánchez M.J., Marcos-Gragera R., Ardanaz E., et al. Lung cancer prognosis in Spain: the role of histology, age and sex. Respir Med 2012, 106:1301-1308.
31. van Weel C., Schellevisb F.G. Comorbidity and guidelines: conflicting interests. Lancet 2006, 18:550-551.
32. Salomaa E.R., Sällinen S., Hiekkanen H., Liippo K. Delays in the diagnosis and treatment of lung cancer. Chest 2005, 128:2282-2288.
33. Ministry of Health. National cancer plan 2011-2013. ; 2011. https://webgate.ec.europa.eu/sanco/heidi/images/f/fc/Italy_National_Oncology_Plan_Summary_English.pdf.